Mount Sinai Beth Israel Medical Center — New York, New York

Mount Sinai Beth Israel Medical Center is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai Beth Israel Medical Center has participated in 4 clinical trials.

Therapeutic areas: Breast Cancer, Non-alcoholic Steatohepatitis, Fibrosis.

Sponsors: Hoffmann-La Roche, Conatus Pharmaceuticals Inc., Beth Israel Medical Center.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Beth Israel Medical Center?

Mount Sinai Beth Israel Medical Center has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Beth Israel Medical Center conducted?

Mount Sinai Beth Israel Medical Center has 4 clinical trials on record. Their work covers Breast Cancer, Non-alcoholic Steatohepatitis, Fibrosis.

Is Mount Sinai Beth Israel Medical Center accredited by Crixeo Health?

Mount Sinai Beth Israel Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Beth Israel Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.